DOCSLIB.ORG

For Good and Bad Times out of Stock Doing the Dow Shuffle Withdrawing

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
For Good and Bad Times out of Stock Doing the Dow Shuffle Withdrawing Ask the Fool Doing the Dow Shuffle I saw that ExxonMobil was Qremoved from the Dow Jones Industrial Average. What hap- nest egg last longer for retirees with- pened? — G.V., Tulsa, Oklahoma Fool’s School My Dumbest Investment The Motley Fool Take drawing smaller percentages, but that Many don’t realize this, but the having at least 50% in stocks is best Out of Stock For Good and ADow Jones Industrial Average Withdrawing Money for most portfolios. (“the Dow”) is an index of only 30 Unless you have a huge nest egg, My dumbest investment was acci- Bad Times companies. Every few years, to bet- in Retirement these rates won’t give you a lot each dentally selling my shares of Shop- ter reflect our diversified economy, Retirement planning is tricky. Not year. With a $300,000 portfolio, for ify at $38, when I had intended to Some businesses are hurt more than only do we need to save enough buy more. I didn’t buy them back others by pandemics and recessions. some components of the Dow are example, a 3% withdrawal would One company with some resistance to money to live on in retirement, give you $9,000 for the year, while to avoid paying an additional trans- ejected to make room for new ones. action fee. Lessons learned: Pay both is pharmacy chain CVS Health The latest move replaces ExxonMo- but we also have to figure out withdrawing 5% would deliver (NYSE: CVS). Yes, the COVID-19 how much we can withdraw from attention when submitting orders — bil, Pfizer and Raytheon Technolo- $15,000. and price is what you pay, value is pandemic has reduced foot traffic in gies with Amgen, Honeywell and our nest eggs each year without Be sure to factor Social Security what you get. — S., online its stores and hurt in-store clinic rev- Salesforce. These changes reduce depleting them too quickly. income into your retirement plan, and enue. But the pandemic is not likely It’s a tough problem, and there’s The Fool Responds: Shopify, the index’s exposure to energy and read up on how to maximize those to be a long-term issue, and CVS no one-size-fits-all solution. Many which offers a widely used has responded nimbly. Indeed, it was traditional pharmaceutical compa- benefits. Consider working a few e-commerce platform, has been look to the “4% rule,” which suggests recently operating more than 1,800 nies, while increasing representation more years, to save and invest even on quite a tear in the past few you withdraw 4% of your nest egg in more, and look into immediate annui- COVID-19 testing sites nationally — of technology and biotechnology. years. It began 2016 at around $25 and it’s offering virtual doctor visits your first year of retirement and then ties, too, as they can allow you to In 2018, General Electric was per share, and began the with its MinuteClinic “E-Clinic” adjust that for inflation in subsequent lock in reliable income. next four years at around shown the door to make way for program. years. That assumes a portfolio mix Many experts recommend being $43, $102, $134 and $404, Walgreens Boots Alliance, while One of the steadiest tailwinds for of stocks and bonds, and it’s likely flexible with withdrawal rates: When respectively. It has recently Apple replaced AT&T in the index CVS Health is that America’s popu- (though not guaranteed) to make your the economy is booming, withdraw been trading around $900 per in 2015. The last major shakeup lation is aging. As life expectancies money last for 30 years. more. When it’s struggling, withdraw share. Clearly, in retrospect, it lengthen and baby boomers hit retire- occurred in 2013, when Alcoa, was a blunder not to buy (and Another approach, suggested less. This is especially true in the ment, reliance on prescription medi- Bank of America and Hewlett- hold) more shares at $38. But at by the 1998 “Trinity study” on early years of your retirement: A big cines to improve overall quality of Packard departed, making room for the time, you didn’t know just retirement savings, is to withdraw stock market crash early on can lead life should increase. Since pharmacy Goldman Sachs, Nike and Visa. how much it would soar. Then, between 3% and 4% each year from to your money running out sooner. sales generate about three-quarters of *** as now, you could have asked CVS revenue, an aging population a stocks-and-bonds portfolio to make This is complicated stuff, so read yourself questions such as: Is this What’s deflation? — L.U., your money last for 15 to 30 years. with easy access to prescription medi- Q a lot more about it — and con- a high-quality, healthy company, cines is a good thing. Federal Way, Washington Examining stocks and bonds from sult a financial adviser. You can with little debt and great growth What’s more, CVS Health has been We all know about inflation, 1926 through 1995, the researchers find fee-only advisers near you at prospects? Is it attractively priced, pushing the personalized medicine which is the steady rise of found that having bonds makes a NAPFA.org. not overvalued? narrative at many of its locations. The A Opinions are mixed on the prices over time. As you might have company has plans to open around stock’s value these days, as it has 1,500 of its HealthHUB clinics suspected, deflation is when prices run up so much. Bulls expect it to fall. That might seem like purely a around the country by the end of next Name That Company keep growing and rising, but bears year, offering services that include good thing, because falling prices think it’s overvalued and might I trace my roots back management of chronic conditions mean you can buy more with pull back. Note that many big bro- like diabetes. your income. to Japan in 1889, when a kerages now offer commission-free With a recent forward-looking Deflation isn’t always good, trading — which could keep you price-to-earnings (P/E) ratio in the young man founded a com- from making future investment though, as it often accompanies a pany to make and sell playing single digits, and a dividend yield recession and/or a struggling econ- decisions based on transaction topping 3.3%, CVS Health deserves omy. It can be part of a cycle where cards. I expanded into other fees. You can learn more about consideration for long-term portfolios. games in the 1960s, electronic good brokerages at our sister site, (The Motley Fool has recommended many people are out of work: They TheAscent.com. postpone purchases because they’ve arcade games in the 1970s — CVS Health.) lost income, then companies lower and home video games in the LAST WEEK’S TRIVIA ANSWER production due to reduced demand, 1970s, as well. In 1989, I introduced then even more people lose jobs. In I trace my roots back to 1846, when two brothers-in-law started a deflationary spiral, the economy one of the first portable handheld packaging baking soda in a kitchen to sell to businesses. (I’m currently game consoles — named for young America’s leading maker of it.) I began using recycled paperboard for contracts rather than grows. Mean- packaging way back in 1907. Today, based in Ewing, New Jersey, I’m a while, businesses (and people) earn- men. That was followed by systems consumer products powerhouse, encompassing brands such as Arm & ing less money can have trouble such as Wii and Switch. My American Hammer, Trojan, OxiClean, Spinbrush, First Response, Nair, Orajel, XTRA, paying down their debts. Kaboom, Orange GLO, L’il Critters, Vitafusion, Batiste, Arrid, WaterPik subsidiary launched in 1980. Shortly and Flawless. I recently sported a market value of around $23 billion, Deflation can be countered by afterward, I introduced two Italian plumb- lowering interest rates, but rates can rake in more than $4 billion annually, and employ almost 5,000 people. Who am I? (Answer: Church & Dwight) only fall so far. ers to the world. I’ve sold more than 750 million game consoles worldwide. Who am I? Want to Invest? Email us at [email protected], and we’ll send Want more information about stocks? you some tips to start investing. Sorry, we can’t provide individual Send us an email to [email protected]. Think you know the answer? We’ll announce it in next week’s edition. financial advice. © 2020 THE MOTLEY FOOL/DIST. BY ANDREWS MCMEEL SYNDICatION 9/24.
Load more

Recommended publications
  • Church & Dwight Annual Report 2020
    Church & Dwight Annual Report 2020 Form 10-K (NYSE:CHD) Published: February 18th, 2020 PDF generated by stocklight.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-10585 CHURCH & DWIGHT CO., INC. (Exact name of registrant as specified in its charter) Delaware 13-4996950 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 500 Charles Ewing Boulevard, Ewing, NJ 08628 (Address of principal executive offices) Registrant’s telephone number, including area code: (609) 806-1200 Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Name of each exchange Symbol(s) on which registered Common Stock, $1 par value CHD New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes ☐ No ☒ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding twelve months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
    [Show full text]
  • 2019 Annual Report
    church & dwight co., inc. Annual Report 2019 In Millions, except per share data 2019 2018 reportedadjusted* reported net sales $ 4,358 $ 4,358 $ 4,146 gross profit margin 45.5 % 45.5 % 44.4% income from operations $ 840 $ 851 $ 792 operating profit margin 19.3 % 19.5 % 19.1% net income $ 616 $ 624 $ 569 net income per share—diluted $ 2.44 $ 2.47 $ 2.27 dividends per share $ 0.91 $ 0.91 $ 0.87 year-end stock price $ 70.35 $ 70.35 $ 65.76 On January 31, 2020, the Company declared a 5.5% increase in its quarterly dividend from $0.2275 per share to $0.24 per share. 2019 key financial results – Worldwide net sales increased 5.1%. – Organic sales increased 4.4%. – Gross profit margin increased 110 basis points to 45.5%. – Adjusted operating profit margin increased 40 basis points to 19.5%. – Net cash from operations increased to a record level of $864.5 million. – Adjusted earnings per share increased 8.8%. net sales earnings per share (in millions of dollars) (in dollars) $2.47(2) $2.27 $4,146 $4,358 $3,776 $1.94(1) 2017 2018 2019 2017 2018 2019 For additional information, see Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. * This annual report includes non-GAAP financial measures, including adjusted income from operations, adjusted operating profit margin, adjusted net income, adjusted EPS, organic sales, and free cash flow, which differ from reported results using Generally Accepted Accounting Principles (GAAP).
    [Show full text]
  • Church & Dwight Co., Inc. 2001 Annual Report
    CHURCH & DWIGHT CO.,INC. 469 NORTH HARRISON STREET CHURCH & DWIGHT CO., INC. 2001 ANNUAL REPORT PRINCETON,NJ 08543-5297 ® On the Internet: www.churchdwight.com ® CHURCH & DWIGHT CO. ,INC.2001 Annual Report CD_406 ARx_IFC.AA2.CDP 4/5/02 10:50 AM Page 1 COMPANY PROFILE CHURCH &DWIGHT 2001 PAGE 1 Church & Dwight Co., Inc., founded in 1846, is the world’s leading producer of sodium bicarbonate, popularly known as baking soda, a natural product which cleans, deodorizes, leavens and buffers. The Company’s ARM & HAMMER brand is one of the nation’s most trusted trademarks for a broad range of consumer and specialty products developed from the base of bicarbonate and related technologies. Church & Dwight Consumer Products now encompass four categories: Laundry, Deodorizing and Household Cleaning, Personal Care and International. Over half of the domestic products are sold under the ARM & HAMMER brand name and derivative trademarks, including ARM & HAMMER DENTAL CARE Toothpaste, ARM & HAMMER FABRICARE Powder Laundry Detergent and ARM & HAMMER SUPER SCOOP Clumping Cat Litter. New in 2001 were the laundry brands XTRA and NICE’N FLUFFY, part of the acquisition of USA Detergents, Inc. in the second quarter. In the third quarter 2001, Church & Dwight acquired the consumer products business of Carter-Wallace, Inc., purchasing outright the ARRID Anti-Perspirant and the LAMBERT KAY Pet Care businesses. Armkel, LLC, Church & Dwight’s 50/50 joint venture with the private equity group Kelso & Company, acquired the remainder of the Carter-Wallace consumer products businesses, including such brands as TROJAN Condoms, NAIR Depilatories and FIRST RESPONSE Home Pregnancy and Ovulation Test Kits.
    [Show full text]
  • Church & Dwight Co., Inc
    cd_2004_an_pdf_cov.qxd 5/3/05 5:16 PM Page 1 2004 CHURCH & DWIGHT CO., INC. ® Annual Report cd_2004_an_pdf_cov.qxd 5/3/05 5:16 PM Page 2 Financial Highlights Dollars in millions, except per share data 2004 2003 CHANGE SALES $1,462 $1,057 +38% INCOME FROM OPERATIONS 172 112 +54% NET INCOME 89 81 +10% NET INCOME PER SHARE - DILUTED 1.36 1.28 +6% DIVIDENDS PER SHARE 0.23 0.21 +10% Additional Information COMBINED SALES (1) (2) $1,702 $1,508 +13% ADJUSTED NET INCOME PER SHARE - DILUTED(1) (3) 1.66 1.33 +25% (1) These are non-GAAP (Generally Accepted Accounting Principles) measures of performance. See notes 2 and 3 for the reconciliations of the non-GAAP numbers to the most directly comparable GAAP financial measure. (2) Includes Armkel sales of $193 million and $411 million for 2004 and 2003, respectively, and Other Equity Affiliates sales of $56 million and $49 million for 2004 and 2003, respectively. Excludes intercompany sales of $9 million for both 2004 and 2003. Management believes this information is useful to investors because the businesses of the Company and its unconsolidated equity investees are managed on a combined basis, and management uses combined performance measures to analyze performance and develop financial objectives. Moreover, since the results of operations of the former Armkel business have been included in Church & Dwight's consolidated statement of income beginning on May 29, 2004, the information enhances comparability over the relevant period. (3) Excludes, in 2004, an accounting charge of $0.10 per share related to the acquisition of the 50% interest in Armkel that the Company did not previously own, as well as charges of $0.20 per share related to the early redemption of debt.
    [Show full text]
  • Companies That Do Test on Animals
    COMPANIES THAT DO TEST ON ANIMALS Frequently Asked Questions Why are these companies included on the 'Do Test' list? The following companies manufacture products that ARE tested on animals. Those marked with a are currently observing a moratorium (i.e., current suspension of) on animal testing. Please encourage them to announce a permanent ban. Listed in parentheses are examples of products manufactured by either the company listed or, if applicable, its parent company. For a complete listing of products manufactured by a company on this list, please visit the company's Web site or contact the company directly for more information. Companies on this list may manufacture individual lines of products without animal testing (e.g., Clairol claims that its Herbal Essences line is not animal-tested). They have not, however, eliminated animal testing from their entire line of cosmetics and household products. Similarly, companies on this list may make some products, such as pharmaceuticals, that are required by law to be tested on animals. However, the reason for these companies' inclusion on the list is not the animal testing that they conduct that is required by law, but rather the animal testing (of personal-care and household products) that is not required by law. What can be done about animal tests required by law? Although animal testing of pharmaceuticals and certain chemicals is still mandated by law, the arguments against using animals in cosmetics testing are still valid when applied to the pharmaceutical and chemical industries. These industries are regulated by the Food and Drug Administration and the Environmental Protection Agency, respectively, and it is the responsibility of the companies that kill animals in order to bring their products to market to convince the regulatory agencies that there is a better way to determine product safety.
    [Show full text]
  • Femfresh - a Summer Essential! Submitted By: PR4 Media Friday, 27 May 2005
    Femfresh - a summer essential! Submitted by: PR4 Media Friday, 27 May 2005 FEMFRESHEN up - for Freshness all day Nowadays, time is of the essence. Whether you’re a busy working mother juggling children and weighed down by work, or a successful career woman living life on-the-go, you have little time for everyday pampering. But there’s a handy thing called FEMFRESH that’s been giving women freshness from am to pm for decades. Each product is designed for those with busy lifestyles who don’t want to compromise their intimate hygiene. Whether you choose the flushable tissues in handy single sachets (a handbag essential and perfect to beat the heat this summer) or soap-free wash (a shower essential), FEMFRESH has just the thing to suit your lifestyle. FEMFRESH’s comprehensive range offers total freshness whenever you need it to give you all-day confidence. All are dermatologically and gynaecologically tested – choose from: Feminine wipes – Great to store in your desk at work or to keep in your bathroom at home. The wipes cleanse, freshen and deodorise and are completely toilet flushable. They are alcohol-free, soap-free and pH balanced. Individual tissues – These sachets are handily flushable, individually wrapped and lightly fragranced. Great for when you’re out and about; pop them in your bag, pocket or wallet for discreet freshness. Feminine spray – Deodorising and delicately fragranced mist. Deo-compact – Lightly fragranced pump spray for instant freshness. Handbag-sized for freshness on the go. Soap-free wash – Perfect for the shower. Start the day as you mean to go on.
    [Show full text]
  • Talented People Superior Products a Successful Integration
    CHURCH & DWIGHT CO., INC. 2002 ANNUAL REPORT ® TALENTED PEOPLE A SUCCESSFUL INTEGRATION: SUPERIOR PRODUCTS FINANCIAL HIGHLIGHTS Dollars in millions, except per share data 2002 2001 CHANGE SALES $1,047.1 $959.7 +9% INCOME FROM OPERATIONS 104.5 93.5 +12% NET INCOME 66.7 47.0 +42% NET INCOME PER SHARE - DILUTED 1.60 1.15 +39% DIVIDENDS PER SHARE 0.30 0.29 +3% Additional Information ADJUSTED NET INCOME PER SHARE - DILUTED(1) (2) 1.61 1.38 +17% (1)Excludes, in 2002, a net charge of $0.01 per share related to the valuation of Armkel’s opening inventories and the allocation of profits under the Armkel joint venture agreement. Excludes, in 2001, a $0.02 per share plant shutdown charge, a $0.06 per share intangibles amortization charge that was discontinued in 2002 with the adoption of accounting standard FAS No. 142, and a $0.15 per share accounting charge related to the step-up of Armkel’s opening inventories. (2)These are non-GAAP (Generally Accepted Accounting Principles) measures of performance which may not be comparable to similar measures of performance used by other companies. For additional information, see Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the Company’s 2003 Proxy Statement. Cover Caption: Talented People and Superior Products Our major accomplishment in 2002 was the successful integration of the USA Detergents and Carter-Wallace consumer products operations, further strengthening Church & Dwight and affiliates as a dynamic consumer packaged goods and specialty chemicals business. COMPANY PROFILE 1 Church & Dwight Co., Inc., founded in 1846, is the world’s leading producer of sodium bicarbonate, popularly known as baking soda, a natural product which cleans, deodorizes, leavens and buffers.
    [Show full text]
  • Companies That Do Test on Animals
    COMPANIES THAT DO TEST ON ANIMALS Frequently Asked Questions Why are these companies included on the ‘Do Test’ list? The following companies manufacture products that ARE tested on animals. Those marked with a are currently observing a moratorium on (i.e., current suspension of) animal testing. Please encourage them to announce a permanent ban. Listed in parentheses are examples of products manufactured by either the company listed or, if applicable, its parent company. For a complete listing of products manufactured by a company on this list, please visit the company’s Web site or contact the company directly for more information. Companies on this list may manufacture individual lines of products without animal testing (e.g., Clairol claims that its Herbal Essences line is not animal-tested). They have not, however, eliminated animal testing from their entire line of cosmetics and household products. Similarly, companies on this list may make some products, such as pharmaceuticals, that are required by law to be tested on animals. However, the reason for these companies’ inclusion on the list is not the animal testing that they conduct that is required by law, but rather the animal testing (of personal care and household products) that is not required by law. What can be done about animal tests required by law? Although animal testing of pharmaceuticals and certain chemicals is still mandated by law, the arguments against using animals in cosmetics testing are still valid when applied to the pharmaceutical and chemical industries. These industries are regulated by the Food and Drug Administration and the Environmental Protection Agency, respectively, and it is the responsibility of the companies that kill animals in order to bring their products to market to convince the regulatory agencies that there is a better way to determine product safety.
    [Show full text]
  • Church & Dwight Co, Inc. 2016 Annual Report
    2016 Annual Report CHURCH & DWIGHT CO., INC. ® 55352c1.indd 1 3/22/17 2:36 PM 2016 Annual Report KEY FINANCIAL HIGHLIGHTS In Millions, except per share data 2015 2016 reported adjusted* reported adjusted* NET SALES $ 3,395 $ 3,395 $ 3,493 $ 3,493 GROSS PROFIT MARGIN 44.5 % 44.5 % 45.5 % 45.7 %(2) INCOME FROM OPERATIONS $ 674 $ 683 $ 724 $ 729 (3) OPERATING PROFIT MARGIN 19.9 % 20.1 % 20.7 % 20.9 %(3) NET INCOME $ 410 $ 434 $ 459 $ 464 (4) NET INCOME PER SHARE — DILUTED $ 1.54 $ 1.62 $ 1.75 $ 1.77 (4) DIVIDENDS PER SHARE $ 0.67 $ 0.67 $ 0.71 $ 0.71 YEAR-END STOCK PRICE $ 42.44 $ 42.44 $ 44.19 $ 44.19 2016 Key Financial Results On February 7, 2017, the Company • Worldwide net sales increased 2.9%. declared a 7% increase in its quarterly • Organic sales increased 3.2%. (1) dividend from $0.1775 per share to • Adjusted gross profi t margin increased 120 basis points to 45.7%. $0.19 per share. • Adjusted operating profi t margin increased 80 basis points to 20.9%. • Net cash from operations increased to a record level of $655 million. • Adjusted earnings per share increased 9.3%. Net sales Earnings per share (in millions of dollars) (in dollars) 2014 2014 2015 2016 $3,298 $1.51 2015 $3,395 $1.62 (4) 2016 $3,493 $1.77 (4) For additional information, see Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.
    [Show full text]
  • Church & Dwight
    Church & Dwight Company, Inc. Annual Report 2019 Form 10-K (NYSE:CHD) Published: February 21st, 2019 PDF generated by stocklight.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 Commission file number 1-10585 CHURCH & DWIGHT CO., INC. (Exact name of registrant as specified in its charter) Delaware 13-4996950 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 500 Charles Ewing Boulevard, Ewing, N.J. 08628 (Address of principal executive offices) Registrant’s telephone number, including area code: (609) 806-1200 Securities registered pursuant to Section 12(b) of the Act: Name of each exchange Title of each class on which registered Common Stock, $1 par value New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act :None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes ☐ No ☒ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding twelve months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
    [Show full text]
  • 2016 Annual Report CHURCH & DWIGHT CO., INC
    2016 Annual Report CHURCH & DWIGHT CO., INC. ® 55352c1.indd 1 3/22/17 2:36 PM 2016 Annual Report KEY FINANCIAL HIGHLIGHTS In Millions, except per share data 2015 2016 reported adjusted* reported adjusted* NET SALES $ 3,395 $ 3,395 $ 3,493 $ 3,493 GROSS PROFIT MARGIN 44.5 % 44.5 % 45.5 % 45.7 %(2) INCOME FROM OPERATIONS $ 674 $ 683 $ 724 $ 729 (3) OPERATING PROFIT MARGIN 19.9 % 20.1 % 20.7 % 20.9 %(3) NET INCOME $ 410 $ 434 $ 459 $ 464 (4) NET INCOME PER SHARE — DILUTED $ 1.54 $ 1.62 $ 1.75 $ 1.77 (4) DIVIDENDS PER SHARE $ 0.67 $ 0.67 $ 0.71 $ 0.71 YEAR-END STOCK PRICE $ 42.44 $ 42.44 $ 44.19 $ 44.19 2016 Key Financial Results On February 7, 2017, the Company • Worldwide net sales increased 2.9%. declared a 7% increase in its quarterly • Organic sales increased 3.2%. (1) dividend from $0.1775 per share to • Adjusted gross profi t margin increased 120 basis points to 45.7%. $0.19 per share. • Adjusted operating profi t margin increased 80 basis points to 20.9%. • Net cash from operations increased to a record level of $655 million. • Adjusted earnings per share increased 9.3%. Net sales Earnings per share (in millions of dollars) (in dollars) 2014 2014 2015 2016 $3,298 $1.51 2015 $3,395 $1.62 (4) 2016 $3,493 $1.77 (4) For additional information, see Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2007/0275021 A1 Lee Et Al
    US 20070275021A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2007/0275021 A1 Lee et al. (43) Pub. Date: Nov. 29, 2007 (54) NEW COSMETIC, PERSONAL CARE, Continuation-in-part of application No. 09/456,196, CLEANING AGENT, AND NUTRITIONAL filed on Dec. 7, 1999, now abandoned. SUPPLEMENT COMPOSITIONS AND Continuation-in-part of application No. 09/456,195, METHODS OF MAKING AND USING SAME filed on Dec. 7, 1999, now abandoned. (75) Inventors: Sean Lee, Karlsruhe (DE); Susanna (60) Provisional application No. 60/192.216, filed on Mar. Kessler, Ergolding (DE); Oliver 27, 2000. Provisional application No. 60/197,162, Forberich, Oberursel (DE); Claire filed on Apr. 14, 2000. Buchwar, Wiesbaden (DE); David C. Greenspan, Gainesville, FL (US) Publication Classification Correspondence Address: (51) Int. Cl. KRAMER LEVN NAFTALIS & FRANKEL A6IR 33/00 (2006.01) LLP A6IR 8/25 (2006.01) INTELLECTUAL PROPERTY DEPARTMENT A61O 1704 (2006.01) 1177 AVENUE OF THE AMERICAS (52) U.S. Cl. .............................. 424/401; 424/59: 424/65; NEW YORK, NY 10036 (US) 424/70.1; 424/724; 510/511 (73) Assignee: SCHOTT AG, MAINZ (DE) (57) ABSTRACT The present invention involves new cosmetic, personal care, (21) Appl. No.: 11/775,615 cleaning agent, biocidal agent, functional food, and nutri tional Supplement compositions. These new compositions (22) Filed: Jul. 10, 2007 incorporate bioactive glass into cosmetics, personal care Related U.S. Application Data items, cleaning agents, biocidal agents, functional foods, and nutritional Supplements. The present invention also involves (60) Division of application No. 09/818,466, filed on Mar. methods of making and methods of using such composi 27, 2001, now Pat.
    [Show full text]